Equities

Kringle Pharma Inc

4884:TYO

Kringle Pharma Inc

Actions
  • Price (JPY)873.00
  • Today's Change5.00 / 0.58%
  • Shares traded49.30k
  • 1 Year change+15.17%
  • Beta1.0428
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments2,1362,7562,138
Total Receivables, Net826883
Total Inventory364350315
Prepaid expenses353191
Other current assets, total0.152.497.76
Total current assets2,6183,2082,635
Property, plant & equipment, net000
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets1.041.041.03
Total assets2,6193,2092,636
LIABILITIES
Accounts payable------
Accrued expenses5.212.963.05
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total204160124
Total current liabilities209163127
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total3882572.28
Total liabilities597420129
SHAREHOLDERS EQUITY
Common stock986052
Additional paid-in capital3,0963,0582,756
Retained earnings (accumulated deficit)(1171)(328)(301)
Treasury stock - common(0.08)(0.08)(0.05)
Unrealized gain (loss)------
Other equity, total0.0000.00
Total equity2,0222,7892,506
Total liabilities & shareholders' equity2,6193,2092,636
Total common shares outstanding5.525.384.33
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.